Clinical Trial Update: Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China

View source ↗

Summary

A clinical trial in China is recruiting participants for a study on early recognition and strategic therapy for fibrotic interstitial lung disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease

Snippet

Sponsor: Dai Huaping | Conditions: Interstitial Lung Disease (ILD) | Status: RECRUITING